Bleximenib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Bleximenib, covering 2026-04-06 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) [Phase 1, Phase 2]